Findings

What do systematic reviews say?

125 questions · 128 findings · 12 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 23 · 18%GRADE not reported 3 · 2.3%Very low 32 · 25%Low 41 · 32%Moderate 19 · 14.8%High 10 · 7.8%

Summary of findings: catgut implantation at acupoints vs valproate

Frequency of adverse effects ‐ anorexia ( · participants with generalised epilepsy

Summary of findings: catgut implantation at acupoints may leads to lower frequency of adverse effects ‐ anorexia ( compared with valproate (low certainty).

1 finding from 1 review

Acupuncture for epilepsy 2014 · Cochrane Headline outcomes only
RR 0.22 [0.05, 0.98]
1 study · 100 participants
Low

Ethosuximide vs lamotrigine

80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

50% or greater reduction in seizure frequency · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

Seizure freedom · absence seizures in children and adolescents

Ethosuximide leads to lower seizure freedom at 12 months compared with lamotrigine (high certainty).

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
RR 0.47 [0.33, 0.67]
1 study · 300 participants
High